HELSINKI -- By Marianne Chang/Korea Biomedical Review correspondent -- Finland might be the happiest nation in the world for the sixth consecutive year but the Finns are not satisfied with just this accolade and are making all-out efforts to ensure their health sector can be equally recognized."Noki
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Takeda Pharmaceuticals, the first Asian-based company to secure a spot among the 10 largest global pharma companies by sales, has redefined its research and development (R&D) strategy for groundbreaking discoveries and cutting-
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- As the 2023 BIO International Convention (BIO 2023) concluded its four-day run on Thursday (local time), Korean pharmaceutical companies showcased their unwavering dedication to advancing healthcare and solidified their positio
Electronic health records (EHR) made their debut in the United States in 1972. However, it took several years for hospitals to fully embrace this technology. Surprisingly, even the popular medical drama Grey's Anatomy didn't introduce the concept of complete hospital digitalization until its ninth s
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Samyang Holdings Biopharm Group said it would open a production base for biodegradable suture yarns with an annual production capacity of 100,000 kilometers of yarns in Hungary on June 13.Hungary was considered an optimal produ
In a world where access to quality healthcare remains a challenge for many, organizations such as Doctors Without Borders have garnered recognition for their commendable efforts. However, another border-transcending organization that deserves acknowledgment is Doctor Hunter, established by Natalya P
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- In today's fast-paced and highly competitive pharmaceutical industry, companies are constantly seeking ways to accelerate innovation and bring new therapies to market.Licensing agreements have become a vital strategy for foster
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Samsung Biologics President and CEO John Rim said the commencement date for the operation of Plant 5 has been rescheduled to April 2025, five months earlier than the initial target of September 2025.Samsung Biologics has emerge
BOSTON, Mass. – By Lee Han-soo/Korea Biomedical Review correspondent – After a prolonged period of uncertainty and disruption caused by the Covid-19 pandemic, the biotechnology industry is experiencing a remarkable resurgence.The 2023 BIO International Convention kicked off its four-day run at the B
Shaperon, a Korean biopharmaceutical company developing innovative immune therapeutics, announced that it would embark on global expansion by showcasing its proprietary inflammatory complex inhibition technology at the 2023 BIO International Convention, to be held in Boston, the U.S., from June 5 to
EuBiologics, the world's No. 1 cholera vaccine manufacturer, said it will seek global partners by promoting its proprietary vaccine manufacturing technology, products and platform at the 2023 BIO International Convention (BIO 2023), to be held in Boston, the U.S., from June 5 to 8.EuBiologics is the
A business enterprise recently announced its participation in ASCO 2023 (American Society of Clinical Oncology 2023) and BIO 2023 (BIO International Convention 2023), throwing its gauntlet in the biopharmaceutical industry. Axceso Biopharma, a new drug developer, is the company.Starting as a cosmeti
Lotte Group's foray into the contract development and manufacturing organization (CDMO) business has gained significant traction since its inception in June 2022 with the establishment of Lotte Biologics. Now, one year later, the company has solidified its position in the industry by taking over a b
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
As the saying goes, “Something old, something new, something borrowed, and something blue," but in Korea, rather than this wedding custom, a shot of botulinum toxin (BTX) is far more commonplace.The high beauty standards in Korea have fostered a culture where high school kids receive double eyelid s
Dong-A ST, which aims to become a global bio company, plans to participate in the 2023 BIO International Convention, to be held in Boston, U.S. ,from June 5 to 8.During the convention, the company will showcase its significant R&D pipeline.As one of Korea's leading pharmaceutical and biotechnology c
At the beginning of this year, the U.S. welcomed a law no longer necessitating animal testing for pharmaceutical pre-clinical trials. However, industry officials expressed skepticism as many technologies that can replace animal testing are still in their infancy.The Ministry of Food and Drug Safety
Samsung Biologics said it will participate in the 2023 BIO International Convention next month. The BIO International Convention is an event organized by the Biotechnology Innovation Organization (BIO) and held annually in major cities with bioclusters in the U.S. The convention serves as an exchang
Merz Aesthetics is a global leader in aesthetics, a field known as "a beauty expert" to healthcare professionals and consumers alike. However, what is less well known is that Merz's leadership in aesthetics has been accompanied by a great deal of research and development (R&D) and scientific endeavo
The Prestige Biopharma Group said Thursday that it would participate in BIO International Convention 2023, the largest international biopharmaceutical event in Boston, Mass., from June 5 to 8.Prestige Biopharma Chairwoman Park So-yeon and Prestige Biologics CEO Hyun Deok-hun will attend the event, o
